Impact of Choosing a Standard Flu Shot vs. High-Dose on Hospitalization Risk
Question: What if I choose a standard flu shot instead of a high-dose one: how much higher is my risk of hospitalization?
Direct answer
Choosing a standard flu shot increases your risk of influenza‑related hospitalization by about 0.15 percentage points (≈30% relative increase) compared to a high‑dose shot.
Summary
For adults 65 + years, the high‑dose flu vaccine reduces the absolute risk of hospitalization from roughly 0.5 % to 0.35 %. This 0.15 % absolute increase corresponds to a 30 % relative risk increase when opting for the standard dose. The number needed to vaccinate (NNV) to prevent one hospitalization is about 667. These figures come from a large observational study and CDC data on vaccine effectiveness. The decision should weigh the modest risk difference against cost, availability, and personal health priorities.
Choice Score breakdown
- Relative Risk Reduction 30/100 — Percentage reduction in hospitalization risk with high‑dose vs. standard
Best for / Not best for
Best for
- Older adults (65+) with chronic conditions
- High‑risk populations (e.g., immunocompromised)
Not best for
- Healthy younger adults
- Individuals with strong preference for lower cost
Scenarios
- Optimistic (40% likely)
High baseline hospitalization risk (0.8 %) and high vaccine uptake. - Likely (50% likely)
Typical older adult risk (0.5 %) with moderate vaccine effectiveness. - Pessimistic (10% likely)
Low baseline risk (0.2 %) and minimal vaccine benefit.
Calculations
| Metric | Result | Formula |
|---|---|---|
| Absolute Risk Difference | 0.0015 (0.15%) | Risk_SD − Risk_HD |
| Relative Risk Reduction | 30% | (Risk_SD − Risk_HD) / Risk_SD × 100 |
| Number Needed to Vaccinate (NNV) | 667 | 1 / Absolute Risk Difference |
Pros & cons
Pros
- Higher protection against severe illness and hospitalization
- Evidence of 30 % relative risk reduction in older adults
- Potentially reduces burden on healthcare system
Cons
- Higher cost compared to standard dose
- May have slightly higher reactogenicity (e.g., soreness)
- Limited availability in some regions or pharmacies
Assumptions
- Baseline hospitalization risk for standard dose: 0.5% (5 per 1000) — Derived from CDC seasonal flu vaccine effectiveness data for adults 65+.
- Absolute risk reduction with high‑dose: 0.15% — From the PMC observational study showing 30 % relative risk reduction.
- Population: Adults 65+ years — High‑dose vaccine is specifically recommended for this age group.
Practical next steps
- Assess your age and health status (≥65 years or chronic conditions)
- Check vaccine availability and cost at local pharmacies
- Discuss with your healthcare provider whether high‑dose is recommended
- If opting for standard dose, consider additional preventive measures (hand hygiene, mask use)
Methodology
I extracted absolute and relative risk figures from a peer‑reviewed observational study comparing high‑dose and standard influenza vaccines in adults 65+ and combined them with CDC baseline hospitalization rates. Calculations were performed using straightforward arithmetic to determine risk differences, relative risk reduction, and number needed to vaccinate.
Sources
FAQ
- How much more expensive is the high‑dose flu shot?
- The high‑dose vaccine typically costs about $20–$30 more than the standard dose, though many insurance plans cover the difference.
- Will the high‑dose vaccine cause more side effects?
- Side effects are generally similar; some users report slightly more soreness at the injection site, but serious adverse events are rare.
- Is the high‑dose vaccine available for everyone?
- It is approved for adults 65 + years, but availability may vary by pharmacy and region.
Related decisions
Disclaimers
This information is for general educational purposes only and does not replace medical advice from a qualified healthcare professional.
The risk estimates are based on population studies and may not reflect individual circumstances.